Advertisement
Screener

FORTREA HOLDINGS INC. (FTRE) Income (Loss) from Continuing Operations, Per Diluted Share

FORTREA HOLDINGS INC. Income (Loss) from Continuing Operations, Per Diluted Share

FORTREA HOLDINGS INC. (FTRE) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$10.81 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-02-26

  • FORTREA HOLDINGS INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was -$0.17.
  • FORTREA HOLDINGS INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$4.14.
  • FORTREA HOLDINGS INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was -$6.25.
  • FORTREA HOLDINGS INC. income (loss) from continuing operations, per diluted share for the quarter ending 2024-09-30 was -$0.21.
  • FORTREA HOLDINGS INC. income (loss) from continuing operations, per diluted share for fiscal 2025 was -$10.81.
  • FORTREA HOLDINGS INC. income (loss) from continuing operations, per diluted share for fiscal 2024 was -$3.03.
  • FORTREA HOLDINGS INC. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$0.36, a 121.95% decline from fiscal 2022.
  • FORTREA HOLDINGS INC. income (loss) from continuing operations, per diluted share for fiscal 2022 was $1.64.
Period endIncome (Loss) from Continuing Operations, Per Diluted Share 3 monthIncome (Loss) from Continuing Operations, Per Diluted Share 6 monthIncome (Loss) from Continuing Operations, Per Diluted Share 9 monthIncome (Loss) from Continuing Operations, Per Diluted Share 12 month
2025-12-31-$10.81
10-K · filed 2026-02-26
2025-09-30-$0.17
10-Q · filed 2025-11-05
-$10.53
10-Q · filed 2025-11-05
2025-06-30-$4.14
10-Q · filed 2025-08-06
-$10.37
10-Q · filed 2025-08-06
2025-03-31-$6.25
10-Q · filed 2025-05-12
2024-12-31-$3.03
10-K · filed 2026-02-26
2024-09-30-$0.21
10-Q · filed 2025-11-05
-$2.21
10-Q · filed 2025-11-05
2024-06-30-$1.11
10-Q · filed 2025-08-06
-$2.01
10-Q · filed 2025-08-06
2024-03-31-$0.89
10-Q · filed 2025-05-12
2023-12-31-$0.36
10-K · filed 2026-02-26
2023-09-30-$0.18
10-Q · filed 2024-11-08
$0.19
10-Q · filed 2024-11-08
2023-06-30$0.28
10-Q · filed 2024-08-12
$0.37
10-Q · filed 2024-08-12
2023-03-31$0.09
10-Q · filed 2024-05-24
2022-12-31$1.64
10-K · filed 2025-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CareDx, Inc. (CDNA)United States$3.174B13.21
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64